Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Demand and Key Producers, 2022-2028
This report studies the global Diphtheria, Tetanus, and Pertussis Combined Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Diphtheria, Tetanus, and Pertussis Combined Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diphtheria, Tetanus, and Pertussis Combined Vaccine that contribute to its increasing demand across many markets.
The global Diphtheria, Tetanus, and Pertussis Combined Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine total production and demand, 2017-2028, (Million Doses)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine total production value, 2017-2028, (USD Million)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Million Doses)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine consumption by region & country, CAGR, 2017-2028 & (Million Doses)
U.S. VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine domestic production, consumption, key domestic manufacturers and share
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Million Doses)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Million Doses)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (Million Doses)
This reports profiles key players in the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Diphtheria, Tetanus, and Pertussis Combined Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diphtheria, Tetanus, and Pertussis Combined Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Million Doses) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market, By Region:
1. How big is the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
2. What is the demand of the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
3. What is the year over year growth of the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
4. What is the production and production value of the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
5. Who are the key producers in the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Diphtheria, Tetanus, and Pertussis Combined Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diphtheria, Tetanus, and Pertussis Combined Vaccine that contribute to its increasing demand across many markets.
The global Diphtheria, Tetanus, and Pertussis Combined Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine total production and demand, 2017-2028, (Million Doses)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine total production value, 2017-2028, (USD Million)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Million Doses)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine consumption by region & country, CAGR, 2017-2028 & (Million Doses)
U.S. VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine domestic production, consumption, key domestic manufacturers and share
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Million Doses)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Million Doses)
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (Million Doses)
This reports profiles key players in the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Diphtheria, Tetanus, and Pertussis Combined Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diphtheria, Tetanus, and Pertussis Combined Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Million Doses) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Inactivated Vaccine
- Other
- 12 Months Below
- 12 Months Above
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
1. How big is the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
2. What is the demand of the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
3. What is the year over year growth of the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
4. What is the production and production value of the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
5. Who are the key producers in the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Introduction
1.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Supply & Forecast
1.2.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.2.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Pricing Trends (2017-2028)
1.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Region
1.3.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Region (2017-2028)
1.3.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Region (2017-2028)
1.3.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Region (2017-2028)
1.3.4 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.3.5 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.3.6 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.3.7 Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Demand (2017-2028)
2.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption by Region
2.2.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption by Region (2017-2022)
2.2.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.4 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.5 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.6 Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.7 South Korea Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.8 ASEAN Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.9 India Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
3 WORLD DIPHTHERIA, TETANUS, AND PERTUSSIS COMBINED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Manufacturer (2017-2022)
3.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Manufacturer (2017-2022)
3.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Diphtheria, Tetanus, and Pertussis Combined Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Diphtheria, Tetanus, and Pertussis Combined Vaccine in 2021
3.6 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Overall Company Footprint Analysis
3.6.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Region Footprint
3.6.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Type Footprint
3.6.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Comparison
4.1.1 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Comparison
4.2.1 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Comparison
4.3.1 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Inactivated Vaccine
5.2.2 Other
5.3 Market Segment by Type
5.3.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Type (2017-2028)
5.3.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type (2017-2028)
5.3.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 12 Months Below
6.2.2 12 Months Above
6.3 Market Segment by Application
6.3.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Application (2017-2028)
6.3.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application (2017-2028)
6.3.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Details
7.1.2 Sanofi Pasteur Major Business
7.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sanofi Pasteur Recent Developments/Updates
7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.2.4 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Details
7.3.2 Mitsubishi Tanabe Pharma Major Business
7.3.3 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.3.4 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.3.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.4 KM Biologics
7.4.1 KM Biologics Details
7.4.2 KM Biologics Major Business
7.4.3 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.4.4 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 KM Biologics Recent Developments/Updates
7.4.6 KM Biologics Competitive Strengths & Weaknesses
7.5 Wuhan Institute of Biological Products
7.5.1 Wuhan Institute of Biological Products Details
7.5.2 Wuhan Institute of Biological Products Major Business
7.5.3 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.5.4 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.5.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.6 Walvax Biotechnology
7.6.1 Walvax Biotechnology Details
7.6.2 Walvax Biotechnology Major Business
7.6.3 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.6.4 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Walvax Biotechnology Recent Developments/Updates
7.6.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.7 Chengdu Institute of Biological Products
7.7.1 Chengdu Institute of Biological Products Details
7.7.2 Chengdu Institute of Biological Products Major Business
7.7.3 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.7.4 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
7.7.6 Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
7.8 Minhai Biotechnology
7.8.1 Minhai Biotechnology Details
7.8.2 Minhai Biotechnology Major Business
7.8.3 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.8.4 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Minhai Biotechnology Recent Developments/Updates
7.8.6 Minhai Biotechnology Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Diphtheria, Tetanus, and Pertussis Combined Vaccine and Key Manufacturers
8.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Manufacturing Costs
8.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Process
8.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Diphtheria, Tetanus, and Pertussis Combined Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Distributors
9.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Introduction
1.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Supply & Forecast
1.2.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.2.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Pricing Trends (2017-2028)
1.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Region
1.3.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Region (2017-2028)
1.3.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Region (2017-2028)
1.3.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Region (2017-2028)
1.3.4 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.3.5 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.3.6 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.3.7 Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Demand (2017-2028)
2.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption by Region
2.2.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption by Region (2017-2022)
2.2.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.4 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.5 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.6 Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.7 South Korea Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.8 ASEAN Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
2.9 India Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028)
3 WORLD DIPHTHERIA, TETANUS, AND PERTUSSIS COMBINED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Manufacturer (2017-2022)
3.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Manufacturer (2017-2022)
3.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Diphtheria, Tetanus, and Pertussis Combined Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Diphtheria, Tetanus, and Pertussis Combined Vaccine in 2021
3.6 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Overall Company Footprint Analysis
3.6.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Region Footprint
3.6.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Type Footprint
3.6.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Comparison
4.1.1 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Comparison
4.2.1 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Comparison
4.3.1 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Inactivated Vaccine
5.2.2 Other
5.3 Market Segment by Type
5.3.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Type (2017-2028)
5.3.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type (2017-2028)
5.3.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 12 Months Below
6.2.2 12 Months Above
6.3 Market Segment by Application
6.3.1 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Application (2017-2028)
6.3.2 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application (2017-2028)
6.3.3 World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Details
7.1.2 Sanofi Pasteur Major Business
7.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sanofi Pasteur Recent Developments/Updates
7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.2.4 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Details
7.3.2 Mitsubishi Tanabe Pharma Major Business
7.3.3 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.3.4 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.3.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.4 KM Biologics
7.4.1 KM Biologics Details
7.4.2 KM Biologics Major Business
7.4.3 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.4.4 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 KM Biologics Recent Developments/Updates
7.4.6 KM Biologics Competitive Strengths & Weaknesses
7.5 Wuhan Institute of Biological Products
7.5.1 Wuhan Institute of Biological Products Details
7.5.2 Wuhan Institute of Biological Products Major Business
7.5.3 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.5.4 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.5.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.6 Walvax Biotechnology
7.6.1 Walvax Biotechnology Details
7.6.2 Walvax Biotechnology Major Business
7.6.3 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.6.4 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Walvax Biotechnology Recent Developments/Updates
7.6.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.7 Chengdu Institute of Biological Products
7.7.1 Chengdu Institute of Biological Products Details
7.7.2 Chengdu Institute of Biological Products Major Business
7.7.3 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.7.4 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
7.7.6 Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
7.8 Minhai Biotechnology
7.8.1 Minhai Biotechnology Details
7.8.2 Minhai Biotechnology Major Business
7.8.3 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
7.8.4 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Minhai Biotechnology Recent Developments/Updates
7.8.6 Minhai Biotechnology Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Diphtheria, Tetanus, and Pertussis Combined Vaccine and Key Manufacturers
8.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Manufacturing Costs
8.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Process
8.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Diphtheria, Tetanus, and Pertussis Combined Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Distributors
9.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Region (2017-2022) & (Million Doses)
Table 7. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Region (2023-2028) & (Million Doses)
Table 8. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Region (2017-2022)
Table 9. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Region (2023-2028)
Table 10. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Region (2017-2022) & (USD/Dose)
Table 11. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Region (2023-2028) & (USD/Dose)
Table 12. Diphtheria, Tetanus, and Pertussis Combined Vaccine Major Market Trends
Table 13. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Million Doses)
Table 14. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption by Region (2017-2022) & (Million Doses)
Table 15. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Forecast by Region (2023-2028) & (Million Doses)
Table 16. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Diphtheria, Tetanus, and Pertussis Combined Vaccine Producers in 2021
Table 18. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Manufacturer (2017-2022) & (Million Doses)
Table 19. Production Market Share of Key Diphtheria, Tetanus, and Pertussis Combined Vaccine Producers in 2021
Table 20. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Manufacturer (2017-2022) & (USD/Dose)
Table 21. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Company Evaluation Quadrant
Table 22. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Site of Key Manufacturer
Table 24. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Type Footprint
Table 25. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Application Footprint
Table 26. Diphtheria, Tetanus, and Pertussis Combined Vaccine Competitive Factors
Table 27. Diphtheria, Tetanus, and Pertussis Combined Vaccine New Entrant and Capacity Expansion Plans
Table 28. Diphtheria, Tetanus, and Pertussis Combined Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Comparison, (2017 & 2021 & 2028) & (Million Doses)
Table 31. United States VS China Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (Million Doses)
Table 32. Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022) & (Million Doses)
Table 36. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022) & (Million Doses)
Table 41. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022) & (Million Doses)
Table 46. Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Type (2017-2022) & (Million Doses)
Table 49. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Type (2023-2028) & (Million Doses)
Table 50. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2017-2022) & (USD/Dose)
Table 53. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2023-2028) & (USD/Dose)
Table 54. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Application (2017-2022) & (Million Doses)
Table 56. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Application (2023-2028) & (Million Doses)
Table 57. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2017-2022) & (USD/Dose)
Table 60. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2023-2028) & (USD/Dose)
Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur Major Business
Table 63. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 64. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sanofi Pasteur Recent Developments/Updates
Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 70. GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Mitsubishi Tanabe Pharma Major Business
Table 75. Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 76. Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 78. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 79. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 80. KM Biologics Major Business
Table 81. KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 82. KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. KM Biologics Recent Developments/Updates
Table 84. KM Biologics Competitive Strengths & Weaknesses
Table 85. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 86. Wuhan Institute of Biological Products Major Business
Table 87. Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 88. Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Wuhan Institute of Biological Products Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
Table 91. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 92. Walvax Biotechnology Major Business
Table 93. Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 94. Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Walvax Biotechnology Recent Developments/Updates
Table 96. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 97. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 98. Chengdu Institute of Biological Products Major Business
Table 99. Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 100. Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Chengdu Institute of Biological Products Recent Developments/Updates
Table 102. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 103. Minhai Biotechnology Major Business
Table 104. Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 105. Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 106. Diphtheria, Tetanus, and Pertussis Combined Vaccine Raw Material
Table 107. Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine Raw Materials
Table 108. Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Distributors
Table 109. Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Customers
Table 1. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Region (2017-2022) & (Million Doses)
Table 7. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Region (2023-2028) & (Million Doses)
Table 8. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Region (2017-2022)
Table 9. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Region (2023-2028)
Table 10. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Region (2017-2022) & (USD/Dose)
Table 11. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Region (2023-2028) & (USD/Dose)
Table 12. Diphtheria, Tetanus, and Pertussis Combined Vaccine Major Market Trends
Table 13. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Million Doses)
Table 14. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption by Region (2017-2022) & (Million Doses)
Table 15. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Forecast by Region (2023-2028) & (Million Doses)
Table 16. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Diphtheria, Tetanus, and Pertussis Combined Vaccine Producers in 2021
Table 18. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Manufacturer (2017-2022) & (Million Doses)
Table 19. Production Market Share of Key Diphtheria, Tetanus, and Pertussis Combined Vaccine Producers in 2021
Table 20. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Manufacturer (2017-2022) & (USD/Dose)
Table 21. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Company Evaluation Quadrant
Table 22. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Site of Key Manufacturer
Table 24. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Type Footprint
Table 25. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Application Footprint
Table 26. Diphtheria, Tetanus, and Pertussis Combined Vaccine Competitive Factors
Table 27. Diphtheria, Tetanus, and Pertussis Combined Vaccine New Entrant and Capacity Expansion Plans
Table 28. Diphtheria, Tetanus, and Pertussis Combined Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Comparison, (2017 & 2021 & 2028) & (Million Doses)
Table 31. United States VS China Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (Million Doses)
Table 32. Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022) & (Million Doses)
Table 36. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022) & (Million Doses)
Table 41. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Diphtheria, Tetanus, and Pertussis Combined Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Domestic Manufacturer, (2017-2022) & (Million Doses)
Table 46. Rest of World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Type (2017-2022) & (Million Doses)
Table 49. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Type (2023-2028) & (Million Doses)
Table 50. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2017-2022) & (USD/Dose)
Table 53. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2023-2028) & (USD/Dose)
Table 54. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Application (2017-2022) & (Million Doses)
Table 56. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production by Application (2023-2028) & (Million Doses)
Table 57. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2017-2022) & (USD/Dose)
Table 60. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2023-2028) & (USD/Dose)
Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur Major Business
Table 63. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 64. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sanofi Pasteur Recent Developments/Updates
Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 70. GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Mitsubishi Tanabe Pharma Major Business
Table 75. Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 76. Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 78. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 79. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 80. KM Biologics Major Business
Table 81. KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 82. KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. KM Biologics Recent Developments/Updates
Table 84. KM Biologics Competitive Strengths & Weaknesses
Table 85. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 86. Wuhan Institute of Biological Products Major Business
Table 87. Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 88. Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Wuhan Institute of Biological Products Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
Table 91. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 92. Walvax Biotechnology Major Business
Table 93. Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 94. Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Walvax Biotechnology Recent Developments/Updates
Table 96. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 97. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 98. Chengdu Institute of Biological Products Major Business
Table 99. Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 100. Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Chengdu Institute of Biological Products Recent Developments/Updates
Table 102. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 103. Minhai Biotechnology Major Business
Table 104. Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
Table 105. Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (Million Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 106. Diphtheria, Tetanus, and Pertussis Combined Vaccine Raw Material
Table 107. Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine Raw Materials
Table 108. Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Distributors
Table 109. Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Diphtheria, Tetanus, and Pertussis Combined Vaccine Picture
Figure 2. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 5. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price (2017-2028) & (USD/Dose)
Figure 6. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 9. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 10. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 11. Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 12. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Demand (2017-2028) & (Million Doses)
Figure 15. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 17. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 18. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 19. Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 20. South Korea Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 21. ASEAN Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 22. India Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 23. Producer Shipments of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Diphtheria, Tetanus, and Pertussis Combined Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Diphtheria, Tetanus, and Pertussis Combined Vaccine Markets in 2021
Figure 26. United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine in United States
Figure 30. Key Producers and Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine in China
Figure 31. Key Producers and Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine in Rest of World
Figure 32. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Type in 2021
Figure 34. Inactivated Vaccine
Figure 35. Other
Figure 36. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2017-2028) & (USD/Dose)
Figure 39. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Application in 2021
Figure 41. 12 Months Below
Figure 42. 12 Months Above
Figure 43. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2017-2028) & (USD/Dose)
Figure 46. Manufacturing Cost Structure Analysis of Diphtheria, Tetanus, and Pertussis Combined Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Diphtheria, Tetanus, and Pertussis Combined Vaccine
Figure 48. Diphtheria, Tetanus, and Pertussis Combined Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Diphtheria, Tetanus, and Pertussis Combined Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Diphtheria, Tetanus, and Pertussis Combined Vaccine Picture
Figure 2. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 5. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price (2017-2028) & (USD/Dose)
Figure 6. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 9. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 10. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 11. Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Production (2017-2028) & (Million Doses)
Figure 12. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Demand (2017-2028) & (Million Doses)
Figure 15. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 17. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 18. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 19. Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 20. South Korea Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 21. ASEAN Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 22. India Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption (2017-2028) & (Million Doses)
Figure 23. Producer Shipments of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Diphtheria, Tetanus, and Pertussis Combined Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Diphtheria, Tetanus, and Pertussis Combined Vaccine Markets in 2021
Figure 26. United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine in United States
Figure 30. Key Producers and Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine in China
Figure 31. Key Producers and Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine in Rest of World
Figure 32. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Type in 2021
Figure 34. Inactivated Vaccine
Figure 35. Other
Figure 36. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2017-2028) & (USD/Dose)
Figure 39. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Application in 2021
Figure 41. 12 Months Below
Figure 42. 12 Months Above
Figure 43. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2017-2028) & (USD/Dose)
Figure 46. Manufacturing Cost Structure Analysis of Diphtheria, Tetanus, and Pertussis Combined Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Diphtheria, Tetanus, and Pertussis Combined Vaccine
Figure 48. Diphtheria, Tetanus, and Pertussis Combined Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Diphtheria, Tetanus, and Pertussis Combined Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
